According to section 25(2), at any time after granting of a patent, but before the expiry of a period of one year from the date of publication […]
According to section 25(2), at any time after granting of a patent, but before the expiry of a period of one year from the date of publication […]
In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr Laboratories, Inc. (hereinafter referred to be as Defendants/Appellants/Teva) Vs. Eli […]